Speaking of SurgOnc artwork

Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers

Speaking of SurgOnc

English - February 14, 2023 06:00 - 13 minutes - 19.1 MB - ★★★★★ - 6 ratings
Natural Sciences Science education globalcancersurgery research surgicaloncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy with and without Reconstruction

Next Episode: Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)

Rick Greene, MD, discusses with Meghan R. Flanagan, MD, MPH, the results of a retrospective population-based study about genetic testing among patients with breast, ovarian, pancreatic and prostate cancers. Dr. Flanagan is author of, “Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.”

Dr. Flanagan is Assistant Professor of Surgery at the University of Washington School of Medicine, Seattle, WA.

http://doi.org/10.1245/S10434-022-12755-Y